- Joined
- 21 August 2008
- Posts
- 2,854
- Reactions
- 8,883
Even at the lower ROE of 10% for the last two financial years MAH looks significantly undervalued? Price to book is x 0.7, p/e is x 5.4
The Quarterly chart shown looks promising, with 4 consecutive positive candles and the price is at a resistance level of ~20c.
The weekly chart not shown suggests to me a maturing inverted head and shoulders with neckline at 20c.
Brokers look to be backing it so that's a caution. Also a bit of a turn-off are the 2 years of losses going back more than 6 years in its history.
Not Held
QUARTERLY
Yea.... Looks too good to be true.
Taking a look at it now though.
as a former ( badly scorched ) DCG share-holder , yes it seems so the me ( a huge premium )Isn't this takeover of Decmil (DCG) a big overpay?
well MAH has certainly experienced a pull-back , but is it a a good deal ( assuming the usual teething pains of a take-over ) ( and an all-cash deal to boot )@divs4ever definitely some synergies it seems but paying a pretty price, maybe the boards are pals. Didn't think of possible MAH rivals looking DCG over. Has certainly put me off MAH, had it on mental watch for a pullback.
Yeah, MAH gets no benefit from the share price divergence of the two companies as MAH says paying with cash and debt facility extension.and an all-cash deal to boot
Nice entry yesterday
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?